BRPI0817472A2 - Composição, métodos para tratamento adjuntivo farmacológico, para controlar ou prevenir progressão de glaucoma em um indivíduo, e para fabricar uma composição - Google Patents

Composição, métodos para tratamento adjuntivo farmacológico, para controlar ou prevenir progressão de glaucoma em um indivíduo, e para fabricar uma composição

Info

Publication number
BRPI0817472A2
BRPI0817472A2 BRPI0817472A BRPI0817472A2 BR PI0817472 A2 BRPI0817472 A2 BR PI0817472A2 BR PI0817472 A BRPI0817472 A BR PI0817472A BR PI0817472 A2 BRPI0817472 A2 BR PI0817472A2
Authority
BR
Brazil
Prior art keywords
composition
glaucoma
individual
controlling
making
Prior art date
Application number
Other languages
English (en)
Inventor
Stephen P Bartels
Original Assignee
Bausch & Lomb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch & Lomb filed Critical Bausch & Lomb
Publication of BRPI0817472A2 publication Critical patent/BRPI0817472A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0817472 2007-09-27 2008-09-08 Composição, métodos para tratamento adjuntivo farmacológico, para controlar ou prevenir progressão de glaucoma em um indivíduo, e para fabricar uma composição BRPI0817472A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97562007P 2007-09-27 2007-09-27
PCT/US2008/075579 WO2009042377A1 (en) 2007-09-27 2008-09-08 Pharmacological adjunctive treatment associated with glaucoma filtration surgery

Publications (1)

Publication Number Publication Date
BRPI0817472A2 true BRPI0817472A2 (pt) 2015-03-24

Family

ID=40043043

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0817472 BRPI0817472A2 (pt) 2007-09-27 2008-09-08 Composição, métodos para tratamento adjuntivo farmacológico, para controlar ou prevenir progressão de glaucoma em um indivíduo, e para fabricar uma composição

Country Status (19)

Country Link
US (1) US20090087443A1 (pt)
EP (1) EP2203160B1 (pt)
JP (1) JP5249336B2 (pt)
KR (1) KR20100065166A (pt)
CN (1) CN101878026B (pt)
AU (1) AU2008305407B2 (pt)
BR (1) BRPI0817472A2 (pt)
CA (1) CA2699599C (pt)
CY (1) CY1114479T1 (pt)
DK (1) DK2203160T3 (pt)
ES (1) ES2424008T3 (pt)
HK (1) HK1145014A1 (pt)
HR (1) HRP20130817T1 (pt)
MX (1) MX2010003198A (pt)
PL (1) PL2203160T3 (pt)
PT (1) PT2203160E (pt)
SI (1) SI2203160T1 (pt)
TW (1) TWI366462B (pt)
WO (1) WO2009042377A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110295782A1 (en) * 2008-10-15 2011-12-01 Alexander Stojadinovic Clinical Decision Model
US20110077270A1 (en) * 2009-04-21 2011-03-31 Pfeffer Bruce A Compositions and Methods for Treating Ocular Inflammation with Lower Risk of Increased Intraocular Pressure
WO2011140517A2 (en) 2010-05-07 2011-11-10 Medicus Biosciences, Llc Methods for treating diseases of the lung
US11083821B2 (en) 2011-08-10 2021-08-10 C.P. Medical Corporation Biocompatible hydrogel polymer formulations for the controlled delivery of biomolecules
US10111985B2 (en) * 2011-08-10 2018-10-30 Medicus Biosciences, Llc Biocompatible hydrogel polymer formulations for the controlled delivery of biomolecules
JP6206987B2 (ja) 2012-05-11 2017-10-04 メディカス バイオサイエンシーズ，エルエルシー 網膜剥離の処置のための生体適合性ヒドロゲル製剤
EP3416982A1 (en) * 2016-02-17 2018-12-26 Novartis AG Tgfbeta 2 antibodies
WO2020152193A1 (en) 2019-01-22 2020-07-30 Akribes Biomedical Gmbh Selective glucocorticoid receptor modifiers for treating impaired skin wound healing

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US6051576A (en) * 1994-01-28 2000-04-18 University Of Kentucky Research Foundation Means to achieve sustained release of synergistic drugs by conjugation
US5773019A (en) * 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
US5902598A (en) * 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
EP1034298B1 (en) * 1997-12-05 2011-11-02 The Scripps Research Institute Humanization of murine antibody
US6242196B1 (en) * 1997-12-11 2001-06-05 Dana-Farber Cancer Institute Methods and pharmaceutical compositions for inhibiting tumor cell growth
WO2000000194A1 (en) * 1998-06-27 2000-01-06 Photogenesis, Inc. Ophthalmic uses of ppargamma agonists and ppargamma antagonists
US6726918B1 (en) * 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
ATE346058T1 (de) * 2002-01-14 2006-12-15 Boehringer Ingelheim Pharma Glucocorticoid mimetika, verfahren zu ihrer herstellung, pharmazeutische formulierungen sie enthaltend und verwendungen davon
AU2003218342B8 (en) * 2002-03-26 2008-07-31 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
AU2003230700A1 (en) * 2002-03-26 2003-10-13 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US6897224B2 (en) * 2002-04-02 2005-05-24 Schering Ag Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
US7074806B2 (en) * 2002-06-06 2006-07-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
AU2003297363A1 (en) * 2002-12-23 2004-07-22 Alcon, Inc. Use of cathepsin k inhibitors for the treatment of glaucoma
WO2004063163A1 (en) * 2003-01-03 2004-07-29 Boehringer Ingelheim Pharmaceuticals, Inc. 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
US20040224992A1 (en) * 2003-02-27 2004-11-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
WO2004097410A1 (en) * 2003-04-30 2004-11-11 Pfizer Products Inc. Screening methods for cataractogenic risk
UY28526A1 (es) * 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
US7795272B2 (en) * 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
WO2005095401A1 (en) * 2004-03-22 2005-10-13 Boehringer Ingelheim Pharmaceuticals, Inc. Alpha-trifluoromethyl alcohols or amines as glucocorticoid mimetics
US20050230128A1 (en) * 2004-04-06 2005-10-20 Smith Bret A Replaceable trench blade
DE102004055633A1 (de) * 2004-11-12 2006-05-18 Schering Ag 5-substituierte Chinolin- und Isochinolin-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
US7417056B2 (en) * 2004-11-12 2008-08-26 Schering Ag 5-substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents
JP2010502635A (ja) * 2006-08-31 2010-01-28 ボーシュ アンド ローム インコーポレイティド 緑内障またはその進行を治療または予防するための組成物と方法
PT2061444E (pt) * 2006-09-11 2011-07-08 Bausch & Lomb Composições e métodos de tratamento, controlo, redução, melhoramento ou prevenção de alergias

Also Published As

Publication number Publication date
WO2009042377A1 (en) 2009-04-02
SI2203160T1 (sl) 2013-11-29
HK1145014A1 (en) 2011-03-25
JP2010540538A (ja) 2010-12-24
AU2008305407B2 (en) 2012-12-20
CA2699599A1 (en) 2009-04-02
DK2203160T3 (da) 2013-09-02
PT2203160E (pt) 2013-10-22
PL2203160T3 (pl) 2013-11-29
EP2203160A1 (en) 2010-07-07
TWI366462B (en) 2012-06-21
MX2010003198A (es) 2010-04-01
CN101878026B (zh) 2013-11-20
CA2699599C (en) 2012-10-23
CY1114479T1 (el) 2016-10-05
JP5249336B2 (ja) 2013-07-31
ES2424008T3 (es) 2013-09-26
AU2008305407A1 (en) 2009-04-02
CN101878026A (zh) 2010-11-03
US20090087443A1 (en) 2009-04-02
KR20100065166A (ko) 2010-06-15
TW200914014A (en) 2009-04-01
HRP20130817T1 (hr) 2013-09-30
EP2203160B1 (en) 2013-07-17

Similar Documents

Publication Publication Date Title
BRPI0817472A2 (pt) Composição, métodos para tratamento adjuntivo farmacológico, para controlar ou prevenir progressão de glaucoma em um indivíduo, e para fabricar uma composição
IL269370B (en) Chemicals, preparations and methods for the treatment and prevention of orthopoxvirus infections and related diseases
BRPI0817664A2 (pt) Nanopartículas, método para preparar nanopartículas e método para tratar terapeuticamente ou profilaticamente um indivíduo
BRPI0717753A2 (pt) Método de tratamento ou redução do risco de uma doença causada por protozoários, e, composição.
BRPI0911351A2 (pt) estrutura de sent, e , prótese de válvula.
BRPI0808163A2 (pt) Composição para aplicação tópica, métodos para tratar uma condição de superfície em um indivíduo, para preparar uma composição, e para usar o kit, e, kit
BRPI1011592A2 (pt) "composição, e, método para fazer manutenção em um furo de poço."
BRPI0915986A2 (pt) composição, métodos para tratar uma condição, para retardar o início de uma condição, para reduzir o risco em um indivíduo de adquirir uma condição e para alterar a expressão de um ou mais genes em um indivíduo
BRPI0820212A2 (pt) Dispositivo para tratamento de fraturas, método para tratamento de fraturas, e, kit para tratamento de fraturas
BRPI0818732A2 (pt) Composições de análogo de prostaglandina e métodos para tratar condições relacionadas epiteliais.
BRPI0815387A2 (pt) composição farmacêutica, método para fazer uma composição farmacêutica e método de tratar uma condição
BRPI0814941A2 (pt) Composição de tratamentode semente, e, método de tratamento de semente.
BRPI0909627A2 (pt) métodos, composições e kits para tratar dores e pruridos
BRPI0807906A2 (pt) Token pessoal tendo habilidades de comunicação aperfeiçoadas para um aplicativo hospedado.
BRPI0815850A2 (pt) "método para tratar, retardar a progressão, prevenir ou atrasar o desenvolvimento de esquizofrenia em um individuo, composiçã farmaceuticamente aceitável, kit e método para reforçar uma resposta de um individuo a um antipsicótico"
EP2192913A4 (en) COMPOSITIONS AND METHODS OF TREATING DEMODEX CASES
GT200800250A (es) Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina
DK2081950T3 (da) Med irinotecanbehandling forbundne ekspressionsprofiler
BR112013019083A2 (pt) combinação de (a) um imunoconjugado, composição farmacêutica, uso de (a) um imunoconjugado, método de tratamento de uma doença em um individuo, método de estímulo de função celular efetora em um indivíduo e kit destinado ao tratamento de uma doença.
BRPI0822012A2 (pt) Derivados de quinazolina de 6,7-dialcóxi úteis para o tratamento de distúrbios relacionados com câncer
WO2009120810A3 (en) Neurodegenerative disorders
BRPI0814167A2 (pt) Composição, e, método
GB2467710B (en) Methods for treating social disorders
BRPI0716668A2 (pt) Plataforma de vergôntea, e, métodos de ajustar uma flutuabilidade e de constuir uma plataforma de vergôntea
EP2323649A4 (en) TREATMENT OF VARIOUS DISORDERS WITH 7,8-DIHYDROXY FLAVONE AND ITS DERIVATIVES

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.